The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.2 (OPD) Tungsten Corporation

22 Dec 2021 07:00

RNS Number : 4199W
Tungsten Corporation PLC
22 December 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Tungsten Corporation plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tungsten Corporation plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

21 December 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests of directors of Tungsten Corporation plc in Tungsten Corporation plc

 

Director

Number of ordinary shares in Tungsten Corporation plc

Percentage of total issued share capital (%)

Tony Bromovsky (1)

934,104

0.74

Paul Cooper

19,500

0.00

Andrew Doman (2)

251,649

0.20

Nicholas Wells (3)

100,000

0.08

 

(1) Held through Forest Nominees Ltd.

(2) Held through Hargreaves Lansdown Nominees Ltd.

(3) Held through Smith and Williamson Nominees Ltd.

 

(b) Directors' rights to subscribe for Tungsten Corporation plc's shares under Tungsten Corporation plc's share plans

 

Award under Tungsten Corporation plc Deferred Share Bonus Plan

 

Director

Number of shares

Vesting date

Exercise price (pence)

Tony Bromovsky

376,166

 

50% vested on 30 October 2021 and 50% on will vest on 30 October 2022 (1)

 

0.438

 

(1) These options become exercisable on an offer to acquire the entire issued share capital of Tungsten Corporation plc being made unconditional in all respects, resulting in a change of control of Tungsten Corporation plc.

 

Long Term Incentive Plan

 

Director

Number of shares

Vesting period

Exercise price (pence)

Paul Cooper

160,467

20 August 2024 (1)

 

0.438

 

(1) These options become exercisable on an offer to acquire the entire issued share capital of Tungsten Corporation plc being made unconditional in all respects, resulting in a change of control of Tungsten Corporation plc.

 

(c) Interests of connected advisers of Tungsten Corporation plc in Tungsten Corporation plc's shares

 

Connected Adviser

Number of ordinary shares in Tungsten Corporation plc

Percentage of total issued share capital (%)

Canaccord Genuity LLC

5,000

0.00

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

22 December 2021

Contact name:

Paul Cooper

Telephone number:

Tel: +44 (0) 20 7280 6980

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEDKDBNBBDBABB
Date   Source Headline
23rd Mar 20212:15 pmRNSCustomer Loss
17th Mar 20214:35 pmRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
12th Feb 20217:00 amEQSTungsten (TUNG): Foundations for growth in place
19th Jan 20214:15 pmRNSHolding(s) in Company
19th Jan 20214:10 pmRNSHolding(s) in Company
15th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 202111:00 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
18th Dec 20204:30 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSInterim Results
11th Dec 20207:00 amRNSNew Customer Win
10th Dec 20201:05 pmRNSHolding(s) in Company
1st Dec 20204:40 pmRNSSecond Price Monitoring Extn
1st Dec 20204:35 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSTrading Update
2nd Nov 20204:31 pmRNSAdditional Listing and Total Voting Rights
2nd Nov 20204:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20201:05 pmRNSHolding(s) in Company
20th Oct 20207:00 amRNSAppointment of Non-Executive Director
16th Oct 20203:50 pmRNSResult of AGM
15th Oct 20205:49 pmRNSAdditional Listing and TVR
2nd Oct 20207:00 amRNSAdditional Listing and Total Voting Rights
23rd Sep 20207:00 amRNSBlock Listing Application
15th Sep 202012:30 pmRNSHolding(s) in Company
11th Sep 20207:00 amRNSDirectorate Change
9th Sep 20207:00 amRNSHolding(s) in Company
7th Sep 20207:00 amRNSFinal Results
20th Jul 20207:00 amRNSTrading Update
2nd Jul 20201:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSReporting Timetable
17th Apr 20207:00 amRNSAppointment of Chief Financial Officer
3rd Apr 202012:05 pmRNSDirector/PDMR Share Dealing
2nd Apr 20202:15 pmRNSDirector/PDMR Share Dealing
31st Mar 20201:40 pmRNSAppointment of Non Executive Director
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 202011:16 amRNSChange of Nominated Adviser
23rd Mar 20207:00 amRNSCOVID-19 Update
19th Mar 202011:45 amRNSDirector/PDMR Share Dealing
16th Mar 20201:15 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSTrading Update for the Nine Months to 31 Jan 2020
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
5th Feb 20202:46 pmRNSDIRECTORATE CHANGE UPDATE
4th Feb 20204:40 pmRNSSecond Price Monitoring Extn
4th Feb 20204:35 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSDIRECTORATE CHANGE
10th Jan 20204:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.